Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftobiprole vs Comparator in Fever and Neutropenia
NCT00529282Phase 3Terminated
- Sponsor
- Basilea Pharmaceutica
- Start
- Oct 2007
- Primary completion
- Jan 2008
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of ceftobiprole medocaril in febrile neutropenia (FN), sponsored by Basilea Pharmaceutica. Started Oct 2007; status: terminated.
02
Drugs
ceftobiprole medocaril
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00529282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529282.